Conclusion: After the patient suffering chronic sinusitis undergoes endoscopic sinus surgery, the treatment of the nasal cavity with Mitomycin (MMC) can reduce the risk of nasal cavity conglutination and increase the curative rate.
Conclusion: After the patient suffering chronic sinusitis undergoes endoscopic sinus surgery, the treatment of the nasal cavity with Mitomycin (MMC) can reduce the risk of nasal cavity conglutination and increase the curative rate.
结论慢性鼻窦炎鼻内镜术后鼻腔局部应用丝裂霉素可以明显降低术腔粘连发生率,从而提高慢性鼻窦炎的手术治愈率。